4 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 1 | Terminated 1 |
Follow Relapsing Chronic Myelogenous Leukemia: new trials by email Literature Review of Relapsing Chronic Myelogenous Leukemia trials Research Report on Relapsing Chronic Myelogenous Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2010-07-01 | 2019-06-18 |
| Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer rituximab, mycophenolate mofetil, tacrolimus - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Terminated | University of Nebraska | 20 | 2009-12-10 | 2023-09-06 |
| Sunitinib in Treating Patients With Idiopathic Myelofibrosis sunitinib malate - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 14 | 2006-09-01 | 2014-05-28 |
| Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant therapeutic allogeneic lymphocytes, aldesleukin, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 7 | 2002-09-01 | 2017-02-15 |
Blast Crisis (4) · Leukemia, Myeloid, Accelerated Phase (4) · Leukemia, Myeloid, Acute (4) · Congenital Abnormalities (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Burkitt Lymphoma (2) · Leukemia, Hairy Cell (2) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2) · Leukemia, Myeloid, Chronic-Phase (2) · Leukemia, Myelomonocytic, Chronic (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2)
Bone Marrow Diseases (4) · Carcinogenesis (4) · Cell Transformation, Neoplastic (4) · Chronic Disease (4) · Disease Attributes (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (4) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4) · Leukemia, Myeloid (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplastic Processes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4)
Antilymphocyte Serum (1) · Busulfan (1) · Cyclophosphamide (1) · Deferasirox (1) · Flow Cytometry (1) · Immunosuppression Therapy (1) · Interleukin-2 (1) · Mycophenolic Acid (1) · Rituximab (1) · Sunitinib (1) · Tacrolimus (1) · Therapeutics (1) · Whole-Body Irradiation (1) · aldesleukin (1) · fludarabine phosphate (1)
City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1) · National Cancer Institute (NCI) (1) · University of Nebraska (1)
United States (4)
Gunnar Ragnarsson (1) · Robert Bociek, MD (1) · Srdan Verstovsek (1) · Vinod Pullarkat, MD (1)
N01CM62202 (1), P01CA018029 (1), P30CA036727 (1)